Literature DB >> 15188884

Antimicrobial peptides derived from heme-containing proteins: hemocidins.

P Mak1, K Wójcik, J Silberring, A Dubin.   

Abstract

Deprived of heme and partially unfolded hemoglobin, myoglobin and cytochrome c display microbicidal activity against a broad spectrum of microorganisms with half maximal lethal dose estimated at micromolar concentrations. The intact proteins were ineffective. Antibacterial activity of these apohemoproteins was also sustained after digestion to approximately 50 amino acids long peptides but further fragmentation abolished microbicidal properties. The most active fragment of apomyoglobin (corresponding to 56-131 region) showed a pronounced effect on the E. coli membrane permeabilization and its action was sensitive to salt as well as to divalent cations concentrations. The membrane-directed effect was specific toward bacteria but no lipopolysaccharide binding properties were observed. No hemolytic properties, even at high peptide concentrations were found; however, a slight but dose-independent cytotoxic effect was observed on fibroblasts and hepatoma cells. The presented data suggest a 'carpet-like' mechanism of the membrane-directed activity and may result from exceptional abilities of hemoprotein-derived peptides to form alpha-helical structures. We postulate that the antimicrobial peptides obtained from the heme-containing proteins should be named hemocidins, in contrast to, e.g., hemorphins displaying opioid-like activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 15188884     DOI: 10.1023/a:1002081605784

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  12 in total

1.  Controlled Enzymatic Hydrolysis: A New Strategy for the Discovery of Antimicrobial Peptides.

Authors:  Estelle Yaba Adje; Rafik Balti; Didier Lecouturier; Mostafa Kouach; Pascal Dhulster; Didier Guillochon; Naïma Nedjar-Arroume
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

2.  Delineation of lipopolysaccharide (LPS)-binding sites on hemoglobin: from in silico predictions to biophysical characterization.

Authors:  Neha Bahl; Ruijuan Du; Imelda Winarsih; Bow Ho; Lisa Tucker-Kellogg; Bruce Tidor; Jeak Ling Ding
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

3.  Hemoglobin promotes Staphylococcus aureus nasal colonization.

Authors:  Melissa Pynnonen; Rachel E Stephenson; Kelly Schwartz; Margarita Hernandez; Blaise R Boles
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823

4.  Full-Length cDNA, Prokaryotic Expression, and Antimicrobial Activity of UuHb-F-I from Urechis unicinctus.

Authors:  Rongli Niu; Xiang Chen
Journal:  Biomed Res Int       Date:  2016-06-07       Impact factor: 3.411

5.  Production and characterization of a new antibacterial peptide obtained from Aeribacillus pallidus SAT4.

Authors:  Syed Aun Muhammad; Safia Ahmed
Journal:  Biotechnol Rep (Amst)       Date:  2015-09-21

6.  Antimicrobial activity and safety evaluation of peptides isolated from the hemoglobin of chickens.

Authors:  Fengjiao Hu; Qiaoxing Wu; Shuang Song; Ruiping She; Yue Zhao; Yifei Yang; Meikun Zhang; Fang Du; Majid Hussain Soomro; Ruihan Shi
Journal:  BMC Microbiol       Date:  2016-12-05       Impact factor: 3.605

Review 7.  Sub-inhibitory Effects of Antimicrobial Peptides.

Authors:  Alexey S Vasilchenko; Eugene A Rogozhin
Journal:  Front Microbiol       Date:  2019-05-24       Impact factor: 5.640

8.  Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.

Authors:  Joseph A Merriman; Kimberly A Nemeth; Patrick M Schlievert
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 9.  Immunological properties of oxygen-transport proteins: hemoglobin, hemocyanin and hemerythrin.

Authors:  Christopher J Coates; Heinz Decker
Journal:  Cell Mol Life Sci       Date:  2016-08-12       Impact factor: 9.261

10.  Did aculeate silk evolve as an antifouling material?

Authors:  Tara D Sutherland; Alagacone Sriskantha; Trevor D Rapson; Benjamin D Kaehler; Gavin A Huttley
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.